Abstract
BACKGROUND: Initial weight loss has been used as a predictor of long-term response to obesity drugs. Discontinuation of drugs has been recommended if weight loss is not ≥1.81 kg (4 lb) in the first month of treatment.
OBJECTIVE: We compared the weight loss response at 6 months of patients losing ≥1.81 kg (responders) vs <1.81 kg (non-responders) in the first month of treatment with the combination of fenfluramine and phentermine.
DESIGN: Outcomes at 6 months in 975 patients treated in a comprehensive program of phentermine (15–30 mg/d) d,l-fenfluramine (20–60 mg/d), were compared for responders vs non-responders.
RESULTS: In the total population, first month weight loss highly correlated with % reduction in body mass index (BMI) after 6 months of treatment (P<0.001). The reduction in baseline BMI after 6 months treatment was greater for the responders (15.9% vs 10%, P<0.02). However, the North American Association for the Study of Obesity (NAASO) guidelines for drug treatment of obesity state that a 5% weight loss produces significant health benefits, and may be used as a criteria for success. At 6 months, 76%, 37% and 14% of the non-respondents had lost ≥5%, ≥10% and ≥15% of baseline BMI, respectively. After 6 months treatment the reductions in serum cholesterol, triglycerides and LDL-cholesterol were 0.55, 0.31 and 0.42 mmol/L, respectively, (P≤0.006), for the non-responders. Adverse effects after 6 months of treatment and the dropout rates after 1 y of treatment were not significantly different for the two groups.
CONCLUSIONS: Although, the first month weight loss predicted the long-term response to phen-fen treatment, it was inadequate in identifying the non-responders and may unnecessarily preclude potential beneficiaries of the treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dhurandhar, N., Blank, R., Schumacher, D. et al. Initial weight loss as a predictor of response to obesity drugs. Int J Obes 23, 1333–1336 (1999). https://doi.org/10.1038/sj.ijo.0801111
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801111
Keywords
This article is cited by
-
Initial weight loss on an 800-kcal diet as a predictor of weight loss success after 8 weeks: the Diogenes study
European Journal of Clinical Nutrition (2010)
-
Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status
International Journal of Obesity (2007)